Evidence for Complementary and Alternative Therapies to Treat Glaucoma

REFERENCES

• Institute of Medicine (US). Committee on the use of complementary and alternative medicine by the American public. In: Complementary and Alternative Medicine in the United States. Washington, DC, USA: National Academies Press (US). 2005;13–17.
   Google Scholar
• Rhee D, Spaeth G, Myers J, et al. Prevalence of the use of complementary and alternative medicine for glaucoma. Ophthalmology. 2002;109(3):438–443. doi:10.1016/S0161-6420(01)01030-2.
   PubMed Web of Science ®Google Scholar
• Hepler R, Frank I. Marihuana smoking and intraocular pressure. JAMA. 1971;217(10):1392. doi:10.1001/jama.1971.03190100074024.
   PubMed Web of Science ®Google Scholar
• Merritt JC, Crawford WJ, Alexander PC, Anduze AL, Gelbart SS. Effect of marihuana on intraocular and blood pressure in glaucoma. Ophthalmology. 1980;87(3):222–228. doi:10.1016/S0161-6420(80)35258-5.
   PubMed Web of Science ®Google Scholar
• Green K. Marijuana smoking vs cannabinoids for glaucoma therapy. Arch Ophthalmol. 1998;116(11):1433–1437. doi:10.1001/archopht.116.11.1433.
   PubMedGoogle Scholar
• Passani A, Posarelli C, Sframeli AT, et al. Cannabinoids in glaucoma patients: the never-ending story. J Clin Med. 2020;9(12):1–20.doi:10.3390/jcm9123978.
   Web of Science ®Google Scholar
• Newman-Casey PA, Robin AL, Blachley T, et al. The most common barriers to glaucoma medication adherence: a cross-sectional survey. Ophthalmology. 2015;122(7):1308–1316.doi:10.1016/j.ophtha.2015.03.026.
   PubMed Web of Science ®Google Scholar
• Lacey J, Cate H, Broadway D. Barriers to adherence with glaucoma medications: a qualitative research study. Eye. 2009;23(4):924–932. doi:10.1038/eye.2008.103.
   PubMed Web of Science ®Google Scholar
• Tsai J, McClure C, R SE, S DG, P JW. Compliance barriers in glaucoma: a systematic classification. J Glaucoma. 2003;12(5):393–398. doi:10.1097/00061198-200310000-00001.
   PubMed Web of Science ®Google Scholar
• Cohen K, Weizman A, Weinstein A. Positive and negative effects of cannabis and cannabinoids on health. Clin Pharmacol Ther. 2019;105(5):1139–1147. doi:10.1002/cpt.1381.
   PubMed Web of Science ®Google Scholar
• Leske C. Ocular perfusion pressure and glaucoma: clinical trial and epidemiologic findings. Curr Opin Ophthalmol. 2009;20(2):73–78. doi:10.1097/ICU.0b013e32831eef82.
   PubMed Web of Science ®Google Scholar
• Leske MC, Wu SY, Hennis A, Honkanen R, Nemesure B. Risk factors for incident open-angle glaucoma. the barbados eye studies. Ophthalmology. 2008;115(1):85–93. doi:10.1016/j.ophtha.2007.03.017.
   PubMed Web of Science ®Google Scholar
• Topouzis F, Coleman AL, Harris A, et al. Association of blood pressure status with the optic disk structure in non-glaucoma subjects: The Thessaloniki Eye Study. Am J Ophthalmol. 2006;142(1):60–67.e1.doi:10.1016/j.ajo.2006.02.055.
   PubMed Web of Science ®Google Scholar
• Jampel H. American glaucoma society position statement: marijuana and the treatment of glaucoma. J Glaucoma. 2010;19(2):75–76. doi:10.1097/IJG.0b013e3181d12e39.
   PubMed Web of Science ®Google Scholar
• Green K, Roth M. Ocular effects of topical administration of 9-Tetrahydrocannabinol in man. Arch Ophthalmol. 1982;100(2):265–267. doi:10.1001/archopht.1982.01030030267006.
   PubMedGoogle Scholar
• Jay WM, Green K. Multiple-drop study of topically applied 1% Δ9-Tetrahydrocannabinol in human eyes. Arch Ophthalmol. 1983;101(4):591–593. doi:10.1001/archopht.1983.01040010591012.
   PubMedGoogle Scholar
• Porcella A, Maxia C, Gessa GL, Pani L. The synthetic cannabinoid WIN55212-2 decreases the intraocular pressure in human glaucoma resistant to conventional therapies. Eur J Neurosci. 2001;13(2):409–412. doi:10.1046/j.0953-816X.2000.01401.x.
   PubMed Web of Science ®Google Scholar
• Pescosolido N, Stefanucci A, Librando A, et al., Evaluation of cannabinoid eye drops on five patients with intractable hypertensive open angle glaucoma. The Ophthalmologist: Clinical and Therapeutic Journal. 2018;2(1):10–12.
   Google Scholar
• Miller S, Ssj H, Leishman E, et al. A GPR119 signaling system in the murine eye regulates intraocular pressure in a sex-dependent manner. Investig Ophthalmol Vis Sci. 2017;58(7):2930–2938.doi:10.1167/iovs.16-21330.
   PubMed Web of Science ®Google Scholar
• Hudson BD, Beazley M, Szczesniak AM, Straiker A, Kelly MEM. Indirect sympatholytic actions at β-adrenoceptors account for the ocular hypotensive actions of cannabinoid receptor agonists. J Pharmacol Exp Ther. 2011;339(3):757–767. doi:10.1124/jpet.111.185769.
   PubMed Web of Science ®Google Scholar
• Lograno MD, Romano MR. Cannabinoid agonists induce contractile responses through G i/o-dependent activation of phospholipase C in the bovine ciliary muscle. Eur J Pharmacol. 2004;494(1):55–62. doi:10.1016/j.ejphar.2004.04.039.
   PubMed Web of Science ®Google Scholar
• Miller S, Daily L, Leishman E, Bradshaw H, Straiker A. ∆ 9 -tetrahydrocannabinol and cannabidiol differentially regulate intraocular pressure. Investig Ophthalmol Vis Sci. 2018;59(15):5904–5911. doi:10.1167/iovs.18-24838.
   PubMed Web of Science ®Google Scholar
• Alapafuja SO, Malamas MS, Shukla V, et al. Synthesis and evaluation of potent and selective MGL inhibitors as a glaucoma treatment. Bioorganic Med Chem. 2019;27(1):55–64.doi:10.1016/j.bmc.2018.11.003.
   PubMed Web of Science ®Google Scholar
• Harris A, Gross J, Moore N, et al. The effects of antioxidants on ocular blood flow in patients with glaucoma. Acta Ophthalmol. 2018;96(2):e237–e241.doi:10.1111/aos.13530.
   PubMed Web of Science ®Google Scholar
• Ahlemeyer B, Krieglstein J. Pharmacological studies supporting the therapeutic use of Ginkgo biloba extract for Alzheimer’s disease. Pharmacopsychiatry. 2003;36(SUPPL. 1):S8–14. doi:10.1055/s-2003-40454.
   PubMedGoogle Scholar
• Tan MS, Yu JT, Tan CC, et al. Efficacy and adverse effects of Ginkgo Biloba for cognitive impairment and dementia: a systematic review and meta-analysis. J Alzheimer’s Dis. 2015;43(2):589–603.doi:10.3233/JAD-140837.
   PubMed Web of Science ®Google Scholar
• Kang JM, Lin S. Ginkgo biloba and its potential role in glaucoma. Curr Opin Ophthalmol. 2018;29(2):116–120. doi:10.1097/ICU.0000000000000459.
   PubMed Web of Science ®Google Scholar
• Zadoyan G, Rokitta D, Klement S, et al. Effect of Ginkgo biloba special extract EGb 761® on human cytochrome P450 activity: a cocktail interaction study in healthy volunteers. Eur J Clin Pharmacol. 2012;68(5):553–560. doi:10.1007/s00228-011-1174-5.
   PubMed Web of Science ®Google Scholar
• Yale S, Glurich I. Analysis of the inhibitory potential of Ginkgo biloba, Echinacea purpurea, and Serenoa repens on the metabolic activity of cytochrome P450 3A4, 2D6, and 2C9. J Altern Complement Med. 2005;11(3):433–439. doi:10.1089/acm.2005.11.433.
   PubMed Web of Science ®Google Scholar
• Mei N, Guo X, Ren Z, Kobayashi D, Wada K, Guo L. Review of Ginkgo biloba-induced toxicity, from experimental studies to human case reports. J Env Sci Heal. 2017;35(1):1–28. doi:10.5558/tfc68612-5.
   Google Scholar
• Lee J, Sohn SW, Kee C. Effect of ginkgo biloba extract on visual field progression in normal tension glaucoma. J Glaucoma. 2013;22(9):780–784. doi:10.1097/IJG.0b013e3182595075.
   PubMed Web of Science ®Google Scholar
• Keltner JL, Johnson CA, Cello KE, et al. Classification of visual field abnormalities in the Ocular Hypertension Treatment Study. Arch Ophthalmol. 2003;121(5):643–650.doi:10.1001/archopht.121.5.643.
   PubMedGoogle Scholar
• Guo X, Kong X, Huang R, et al. Effect of ginkgo biloba on visual field and contrast sensitivity in Chinese patients with normal tension glaucoma: a randomized, crossover clinical trial. Investig Ophthalmol Vis Sci. 2013;55(1):110–116.doi:10.1167/iovs.13-13168.
   Web of Science ®Google Scholar
• Shim SH, Kim JM, Choi CY, Kim CY, Park KH. Ginkgo biloba extract and bilberry anthocyanins improve visual function in patients with normal tension glaucoma. J Med Food. 2012;15(9):818–823. doi:10.1089/jmf.2012.2241.
   PubMed Web of Science ®Google Scholar
• Sari MD, Sihotan AD, Lelo A. Gingko biloba extract effect on oxidative stress marker malonildialdehyde, redox enzyme gluthation peroxidase, visual field damage, and reitnal nerve fiber layer thickness in primary open angle glaucoma. International Journ of PharmTech Res. 2016;9(3): 158–166. https://sphinxsai.com/2016/ph_vol9_no3/1/(158-166)V9N3PT.pdf
   Google Scholar
• Hirooka K, Tokuda M, Miyamoto O, Itano T, Baba T, Shiraga F. The Ginkgo biloba extract (EGb 761) provides a neuroprotective effect on retinal ganglion cells in a rat model of chronic glaucoma. Curr Eye Res. 2004;28(3):153–157. doi:10.1076/ceyr.28.3.153.26246.
   PubMed Web of Science ®Google Scholar
• Ige M, Liu J. Herbal medicines in glaucoma treatment. Yale J Biol Med. 2020;93(2):347–353. doi:10.1016/j.lfs.2005.09.012.
   PubMed Web of Science ®Google Scholar
• Ziberna L, Lunder M, Moze S, et al. Acute cardioprotective and cardiotoxic effects of bilberry anthocyanins in ischemia-reperfusion injury: beyond concentration-dependent antioxidant activity. Cardiovasc Toxicol. 2010;10(4):283–294.doi:10.1007/s12012-010-9091-x.
   PubMed Web of Science ®Google Scholar
• Rhee D, Katz J, Spaeth G, Myers J. Complementary and alternative medicine for glaucoma. Surv Ophthalmol. 2001;46(1):43–55. doi:10.1016/S0039-6257(01)00233-8.
   PubMed Web of Science ®Google Scholar
• Manabe K, Kaidzu S, Tsutsui A, et al. Effects of French maritime pine bark/bilberry fruit extracts on intraocular pressure for primary open-angle glaucoma. J Clin Biochem Nutr. 2021;68(1):67–72.doi:10.3164/JCBN.20-50.
   PubMed Web of Science ®Google Scholar
• Ohguro H, Ohguro I, Yagi S. Effects of black currant anthocyanins on intraocular pressure in healthy volunteers and patients with glaucoma. J Ocul Pharmacol Ther. 2013;29(1):61–67. doi:10.1089/jop.2012.0071.
   PubMed Web of Science ®Google Scholar
• Ohguro H, Ohguro I, Katai M, Tanaka S. Two-year randomized, placebo-controlled study of black currant anthocyanins on visual field in glaucoma. Ophthalmologica. 2012;228(1):26–35. doi:10.1159/000335961.
   PubMed Web of Science ®Google Scholar
• Yoshida K, Ohguro I, Ohguro H. Black currant anthocyanins normalized abnormal levels of serum concentrations of endothelin-1 in patients with glaucoma. J Ocul Pharmacol Ther. 2013;29(5):480–487. doi:10.1089/jop.2012.0198.
   PubMed Web of Science ®Google Scholar
• Law SK, Wang L, Li T. Acupuncture for glaucoma. Cochrane Database Syst Rev. 2013;5(CD006030). doi:10.1002/14651858.CD006030.pub4.
   PubMedGoogle Scholar
• Her J, Liu P, Cheng N, et al. Intraocular pressure-lowering effect of auricular acupressure in patients with glaucoma: a prospective, single-blinded, randomized controlled trial. J Altern Complement Med. 2010;16(11):1177–1184. doi:10.1089/acm.2010.0020.
   PubMed Web of Science ®Google Scholar
• Law SK, Lowe S, Law SM, Giaconi JA, Coleman AL, Caprioli J. Prospective evaluation of acupuncture as treatment for glaucoma. Am J Ophthalmol. 2015;160(2):256–265. doi:10.1016/j.ajo.2015.04.033.
   PubMed Web of Science ®Google Scholar
• Chen SY, Yieh FS, Liao WL, Li TC, Hsieh CL. Effect of acupuncture on intraocular pressure in glaucoma patients: a single-blinded, randomized, controlled trial. Evidence-based Complement Altern Med. 2020. Published online. doi:10.1155/2020/7208081.
   Google Scholar